• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Coloplast Launches New Catheter in the U.S.

    Josh Ghaim and Sachin Jain Join Cue Health Board of Directors

    NAMSA Relaunches Medtech Outsourcing Solution

    Rollomatic Inc. Welcomes Joe Kane as CEO

    Alveo Technologies Announces New Executive Leadership
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Forefront Medical Technology

    JBC Technologies

    Fusion Biotec Inc.

    Arthur G. Russell Co. Inc., The

    LEMO USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Forefront Medical Technology

    JBC Technologies

    Fusion Biotec Inc.

    Arthur G. Russell Co. Inc., The

    LEMO USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    BioSig Technologies To Commence First–in-Human Studies at Mayo Clinic

    Institution to become the second center after TCAI to launch the studies with PURE EP System.

    BioSig Technologies To Commence First–in-Human Studies at Mayo Clinic
    The PURE EP System. Image courtesy of Biosig Technologies Inc.
    Related CONTENT
    • Corindus’ Technology Successfully Used in World’s First-in-Human Telerobotic Coronary Intervention
    • Medical Leaders Join BioSig Clinical Advisory Board
    • FDA Clears MRI Interventions' ClearPoint PURSUIT Neuro Aspiration System
    • BioSig Technologies Announces New Research Program With Mayo Clinic
    • Eko Collaborates With Mayo Clinic on Machine Learning-Based Algorithm for Heart Disease Screening
    Globe Newswire01.23.19
    BioSig Technologies Inc. has signed an agreement with the Mayo Clinic to conduct first-in-human studies using the PURE EP System.
     
    These first-in-human studies are aimed at validating the safety and efficacy of the PURE EP System during mapping and ablation procedures in the cardiac EP lab. Mayo Clinic has conducted 12 pre-clinical studies to date using the PURE EP System, results of which have been published in a number of journals, including The Journal of Innovations in Cardiac Rhythm Management. Collected data and physician experience arising from this non-randomized first-in-human study will be documented and presented in the form of publications and lay the foundation for future larger clinical trials. 
     
    The Mayo Clinic becomes the second center to launch pilot first-in-human studies ahead of BioSig’s targeted commercial launch of its first product, PURE EP System in 2019. BioSig announced on Nov. 28, 2018, that it began installations of the first systems at Texas Cardiac Arrhythmia Institute in Austin, Texas. BioSig signed a 10-year collaboration agreement with the Mayo Clinic in March 2017 and announced a new research agreement focusing on development of additional advanced features and potential new applications of the PURE EP System late last fall.
     
    The study will be conducted under leadership of K. L. Venkatachalam, M.D., and Samuel J. Asirvatham, M.D., medical director of the Electrophysiology Laboratory.

    “We are extremely proud to be working with Dr. Venkatachalam and Dr. Asirvatham on collection of the first-in-human data. Our continued collaboration with Mayo Clinic remains one of our biggest assets, and we couldn’t wish for a better team to launch this new clinical milestone, which is essential to unlocking better treatments for all arrhythmia patients and creating shareholder value for everyone who continues to support our company,” commented Kenneth L. Londoner, chairman and CEO of BioSig Technologies.
     
    The PURE EP System aims to minimize noise and artifacts and acquire high-fidelity cardiac signals. Improving fidelity of acquired cardiac signals may potentially increase the diagnostic value of these signals, thereby possibly improving accuracy and efficiency of the EP studies and related procedures. The PURE EP System takes advantage of improvements in hardware design as well as signal processing software to produce better quality signals to distinguish scar from healthy tissue, and also use tissue properties to estimate the force being applied to tissue. These advantages could improve safety and efficacy of ablation procedures. Initial pre-clinical studies have shown the benefits of this approach.
     
    The Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.
     
    BioSig Technologies is a medical technology company developing a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace. Led by a management team and a veteran, independent Board of Directors, Los Angeles, Calif.-based BioSig Technologies is preparing to commercialize its PURE EP System. The technology has been developed to address an unmet need in a large and growing market.
     
    The company’s first product, PURE EP System, is a cardiac signal acquisition and display system which is engineered to assist electrophysiologists in clinical decision-making during procedures to diagnose and treat patients with abnormal heart rates and rhythms. BioSig’s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, atrial fibrillation and ventricular tachycardia. BioSig has partnered with Minnetronix on technology development and has received U.S. Food and Drug Administration 510(k) clearance for the PURE EP System in August 2018.
    Related Searches
    • heart
    • ventricular tachycardia
    • institute
    • it
    Related Knowledge Center
    • Cardiovascular
    Suggested For You
    Corindus’ Technology Successfully Used in World’s First-in-Human Telerobotic Coronary Intervention Corindus’ Technology Successfully Used in World’s First-in-Human Telerobotic Coronary Intervention
    Medical Leaders Join BioSig Clinical Advisory Board Medical Leaders Join BioSig Clinical Advisory Board
    FDA Clears MRI Interventions FDA Clears MRI Interventions' ClearPoint PURSUIT Neuro Aspiration System
    BioSig Technologies Announces New Research Program With Mayo Clinic BioSig Technologies Announces New Research Program With Mayo Clinic
    Eko Collaborates With Mayo Clinic on Machine Learning-Based Algorithm for Heart Disease Screening Eko Collaborates With Mayo Clinic on Machine Learning-Based Algorithm for Heart Disease Screening
    Baxter and Mayo Clinic Partner to Establish Renal Care Center of Excellence in the U.S. Baxter and Mayo Clinic Partner to Establish Renal Care Center of Excellence in the U.S.
    FundamentalVR, Mayo Clinic Launch Alliance and Joint Development Agreement FundamentalVR, Mayo Clinic Launch Alliance and Joint Development Agreement
    3 Ways the New Apple Watch Will Impact the Medical Device Industry 3 Ways the New Apple Watch Will Impact the Medical Device Industry
    BioSig Technologies Receives FDA 510(k) Clearance for PURE EP System BioSig Technologies Receives FDA 510(k) Clearance for PURE EP System
    Director – Retail Operations & Medical Products Director – Retail Operations & Medical Products
    FDA OKs BioSig FDA OKs BioSig's Pure EP System for Electrophysiology
    Mayo Clinic Elects New President & CEO Mayo Clinic Elects New President & CEO
    10. Baxter International 10. Baxter International

    Related Breaking News

    • Cardiovascular
      Corindus’ Technology Successfully Used in World’s First-in-Human Telerobotic Coronary Intervention

      Corindus’ Technology Successfully Used in World’s First-in-Human Telerobotic Coronary Intervention

      CorPath telerobotic interventional platform can deliver specialized cardiovascular treatment to remote, underserved patient populations.
      Business Wire 01.22.19

    • Medical Leaders Join BioSig Clinical Advisory Board

      Medical Leaders Join BioSig Clinical Advisory Board

      New physician board to drive adoption of PURE EP System.
      Globe Newswire 01.16.19

    • Neurological | Surgical
      FDA Clears MRI Interventions

      FDA Clears MRI Interventions' ClearPoint PURSUIT Neuro Aspiration System

      Device provides controlled aspiration of blood, clotted blood, cystic components of tumors, abscesses, colloid cysts, and cerebral spinal fluid.
      GlobeNewswire 01.04.19


    • BioSig Technologies Announces New Research Program With Mayo Clinic

      BioSig Technologies Announces New Research Program With Mayo Clinic

      New agreement to focus on enhanced features of PURE EP System and future potential clinical applications.
      Globe Newswire 12.27.18

    • Cardiovascular
      Eko Collaborates With Mayo Clinic on Machine Learning-Based Algorithm for Heart Disease Screening

      Eko Collaborates With Mayo Clinic on Machine Learning-Based Algorithm for Heart Disease Screening

      Eko’s software, a smart digital stethoscope, and Mayo’s data and tech are combined to help doctors detect life-threatening conditions earlier.
      Globe Newswire 12.11.18

    Loading, Please Wait..

    Trending
    • The Future Of Biomedical Engineering Advancements
    • Cirtec Medical Corporation Acquires Precision Components Business From QMD
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    • A New Approach To Post-Market Surveillance
    • Philips Names New Supervisory Board Chairman
    Breaking News
    • The Producto Group Appoints Mark C. Rauenzahn as Chief Executive Officer
    • Coloplast Launches New Catheter in the U.S.
    • Josh Ghaim and Sachin Jain Join Cue Health Board of Directors
    • NAMSA Relaunches Medtech Outsourcing Solution
    • Rollomatic Inc. Welcomes Joe Kane as CEO
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Dr. Ranjini Murthy Joins Azelis Americas as SVP of Commercial and Digital Excellence
    Pomegranate Extract Tied to Gut and Skin Microbiome Benefits
    Berry Health Benefits Symposium Includes Panel on Dietary Supplements
    Coatings World

    Latest Breaking News From Coatings World

    EPS Launches New Acrylic DIrect-to-Metal Polymer
    Evonik, Partners Launch PlasCO₂ Project for C4 Chemicals Production
    Masco Corporation Reaches $5 Million Milestone in Grant Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Coloplast Launches New Catheter in the U.S.
    Josh Ghaim and Sachin Jain Join Cue Health Board of Directors
    NAMSA Relaunches Medtech Outsourcing Solution
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pfizer Revenues Soar to Record-Breaking $100B in 2022
    iuvo BioScience Appoints Industry Exec to Lead Lab Biz
    Seqens Opens Flagship R&D Center in Greater Boston
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    U.S. Prestige Beauty Industry Sales Revenue Grew 15% in 2022
    Personal Care Market Forecasted to Grow at CAGR of 6.4% from 2022-2027
    P&G Designs Recyclable Pump Dispenser
    Happi

    Latest Breaking News From Happi

    Nutricosmetics & Wellness Market Expected to Grow 5% by 2033
    Anastasia Beverly Hills Celebrates 25th Anniversary
    Henkel Honors Leading Suppliers During American Cleaning Institute Convention Week
    Ink World

    Latest Breaking News From Ink World

    UFlex Exhibits Sustainable Printing, Packaging Solutions at Plast India 2023
    Early-Bird Registration Opens for Print UV 2023
    Arkema Partners with Research Institute to Open Lab in France
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    FLAG achieves record membership in 2022
    AWA to host 23rd Global Release Liner Industry Conference & Exhibition
    Color-Logic certifies Ecofoil digital labestock for cut sheet printers
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Ahlstrom Launches New Generation FluoroFree Technology
    Berry to Begin Production at India Healthcare Hub Early This Year
    FiltXPO to be Held in October
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Mobi-C Cervical Disc Replacement Procedures Top 200,000
    OPUM, Corflex Global Partner on Knee Assessment Technology
    ODT's Most-Read Stories This Week—Jan. 28
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Textiles are Smarter with Durak SilverPro Conductive Threads
    Arkema Partners with Research Institute to Open Lab in Mulhouse, France
    Veridos to Become Majority Shareholder in NetSeT

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login